S&P 500 & Equities·The Motley Fool· 2h ago

ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025

ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025

The Big Market Report Take

Specializing in branded and generic pharmaceuticals, this sector player reported a notable insider sale amid a stable transaction pattern.

Not financial advice. The Big Market Report aggregates news for informational purposes only. Nothing on this site constitutes investment advice. Equities and other securities are subject to market risk. Always do your own research and consult a qualified financial advisor before making any investment decisions. Full disclaimer →

Never miss a story

More from this section